Stem cells are undifferentiated cells that have the ability to divide and develop into many specialised cell types. They are found in embryos, where they give rise to every tissue in the body, and in some adult tissues, where they replace worn-out or damaged cells throughout life.
What is cell differentiation and why does it matter?
Picture this: a single fertilised egg, barely visible to the naked eye, divides again and again until it produces a human being containing around 37 trillion cells — and those cells have organised themselves into roughly 200 distinct types. A red blood cell is a flattened biconcave disc, packed with haemoglobin and lacking a nucleus entirely. A neurone stretches thin projections that can extend a metre or more. A muscle cell contains bundles of contractile proteins. Yet all of these began with identical DNA.
Differentiation is the process by which a cell develops a specialised structure and function, switching on certain genes while permanently silencing others. A muscle cell activates genes for actin and myosin; a pancreatic beta cell activates genes for insulin production; a photoreceptor cell in the retina activates genes for light-sensitive pigments. Once a cell has differentiated, it almost always loses the ability to become any other type — the gene-switching is largely permanent.
Stem cells are the remarkable exception: they have not yet differentiated. They retain the potential to divide and produce daughter cells that can become specialised. This is what makes them so scientifically and medically significant — and it is what we explore in this guide.
What are embryonic stem cells?
In the first four to five days after fertilisation, before the embryo implants in the uterine wall, it exists as a hollow sphere of around 150 cells called a blastocyst. The inner cell mass of this blastocyst contains embryonic stem cells. At this stage they are pluripotent — meaning they can differentiate into virtually any of the ~200 cell types found in the human body. ("Pluripotent" comes from the Latin for "many" and "powerful".)
Embryonic stem cells can be cultured in the laboratory: given the right chemical signals, they continue to divide indefinitely while remaining undifferentiated, or they can be guided down specific developmental pathways to produce heart muscle cells, nerve cells, or insulin-producing beta cells. This flexibility makes them extremely valuable for medical research.
The significant ethical issue is that extracting embryonic stem cells destroys the blastocyst. Some people consider a blastocyst — even at four days old and composed of 150 cells with no nervous system, no consciousness, and no ability to feel pain — to be a potential human life, and object to its destruction for research purposes. This ethical debate is ongoing in society and is an important part of the KS3 science curriculum.
What are adult stem cells?
Adult stem cells are found in specific tissues throughout the body after birth. They serve as a repair and replenishment system, replacing cells that are lost through normal wear and tear or injury. Unlike embryonic stem cells, adult stem cells are multipotent — they can only differentiate into a limited range of cell types related to the tissue in which they reside.
The best-understood example is bone marrow stem cells, which continuously produce red blood cells, white blood cells, and platelets — but do not differentiate into liver cells, neurones, or skin cells. The gut lining is replaced every few days by stem cells in the intestinal crypts. The skin is regenerated by stem cells in the deepest layer of the epidermis.
Because adult stem cells come from the patient's own body (or a closely matched donor), they raise fewer ethical concerns than embryonic stem cells. However, their limited range of possible cell types and the difficulty of growing them in large quantities in the laboratory make them less versatile. The most established therapeutic use of adult stem cells is the bone marrow transplant: a patient with leukaemia (blood cancer) has their cancerous bone marrow destroyed by chemotherapy or radiotherapy, then receives an infusion of healthy donor bone marrow stem cells, which repopulate the marrow and restore blood cell production.
What medical conditions could stem cells treat?
| Condition | How stem cells could help | Stage of development |
|---|---|---|
| Leukaemia (blood cancer) | Bone marrow transplant replaces cancerous blood-producing cells | Established treatment (adult stem cells) |
| Type 1 diabetes | Insulin-producing pancreatic beta cells grown from stem cells and transplanted | Research / early clinical trials |
| Parkinson's disease | Dopamine-producing neurones grown from stem cells and transplanted into brain | Research / early clinical trials |
| Spinal cord injury | Nerve cells grown from stem cells to repair damaged spinal tissue | Research |
| Heart disease | Heart muscle cells grown from stem cells to repair damaged heart tissue | Research |
| Burns | Skin stem cells used to grow replacement skin for grafting | Established treatment (limited) |
It is important to be honest about the distinction between treatments that exist now and those that are still in research phases. The promise is real, but so is the complexity — growing the right cell type in sufficient quantities, ensuring the cells integrate correctly into existing tissue, and preventing rejection are all significant hurdles. Science communicators sometimes overstate the timeline, so a critical eye is valuable here.
What is therapeutic cloning?
Therapeutic cloning is a proposed technique designed to solve the rejection problem — when a transplanted cell or tissue is attacked by the recipient's immune system because it carries different surface proteins.
The process works as follows:
- A body cell is taken from the patient who needs treatment
- Its nucleus — containing the patient's complete DNA — is removed
- This nucleus is inserted into an empty egg cell from which the original nucleus has been removed
- The egg cell is stimulated to begin dividing, forming a blastocyst
- Embryonic stem cells are extracted from this blastocyst — cells that carry the patient's own DNA
- These cells are guided to differentiate into the required cell type and transplanted back into the patient
Because the resulting stem cells carry the patient's DNA, the immune system should recognise them as "self" and not mount a rejection response. This is the theoretical advantage over using donor stem cells.
The ethical objection mirrors that of standard embryonic stem cell research: a cloned embryo is created and then destroyed. The word "cloning" also sometimes causes public alarm, though it is worth emphasising that therapeutic cloning is entirely distinct from reproductive cloning (producing a cloned individual), which is not a goal of this research and is banned in the UK.
What are the ethical arguments about stem cell research?
Science rarely happens in a social vacuum, and stem cell research is one of the clearest examples of science intersecting with deeply held ethical and philosophical views. KS3 students are expected to engage with both sides thoughtfully.
Arguments in favour of embryonic stem cell research:
- A blastocyst at four to five days has no nervous system, no capacity for consciousness, and no ability to feel pain
- In the UK, many embryos used in research come from IVF (in vitro fertilisation) clinics, where surplus embryos would otherwise be disposed of
- The potential to treat devastating and currently incurable diseases is immense
- Adult stem cells, while valuable, cannot substitute for all the capabilities of embryonic stem cells
Arguments against:
- From the moment of fertilisation, the embryo carries the complete, unique genetic blueprint of a human being; many people argue this confers moral status
- Destroying embryos, even very early ones, treats potential human life as a means to a medical end
- An alternative approach — induced pluripotent stem cells (iPSCs), in which adult body cells are genetically reprogrammed to behave like embryonic stem cells — was discovered in 2006 and is being actively developed, potentially removing the need to use embryos at all
Scientists, ethicists, religious traditions, and lawmakers all hold a range of positions on these questions. In the UK, human embryonic stem cell research is permitted under strict regulation by the Human Fertilisation and Embryology Authority (HFEA), up to fourteen days after fertilisation.
Frequently asked questions
What is the difference between embryonic and adult stem cells?
Embryonic stem cells, taken from blastocysts (very early embryos), are pluripotent — they can differentiate into virtually any of the ~200 cell types in the human body. This makes them scientifically very powerful but ethically controversial, as extracting them destroys the embryo. Adult stem cells, found in tissues like bone marrow and skin, are multipotent — they can only differentiate into a limited range of cell types related to the tissue they come from. They raise fewer ethical issues but are more restricted in their potential medical applications.
What are induced pluripotent stem cells (iPSCs)?
Induced pluripotent stem cells are adult body cells (typically skin cells or blood cells) that have been genetically reprogrammed in the laboratory to behave like embryonic stem cells. They can divide indefinitely and differentiate into many cell types. Discovered by Shinya Yamanaka in 2006 (Nobel Prize 2012), iPSCs offer the versatility of embryonic stem cells without destroying embryos — potentially resolving the main ethical objection. However, the reprogramming process can introduce genetic errors, and there are concerns about whether iPSC-derived cells might cause tumours. Research is ongoing.
Why might a bone marrow transplant patient need to take immunosuppressant drugs?
When a patient receives a bone marrow transplant from a donor, the donor's bone marrow contains stem cells with slightly different surface proteins (antigens) from the patient's own cells. The patient's immune system may recognise these donor cells as foreign and attack them (rejection). Conversely, donor immune cells in the transplant may attack the patient's body (graft-versus-host disease). Immunosuppressant drugs reduce the immune response to prevent this. However, they also lower the patient's ability to fight infections, so careful monitoring and infection prevention are essential during recovery.
Could we one day grow whole organs from stem cells?
This is an active area of research called tissue engineering or regenerative medicine. Scientists have already grown simple structures — skin for grafting, trachea (windpipe), bladder, and small sections of intestine — using scaffolds seeded with stem cells. Growing complex organs like hearts, kidneys, or livers remains a significant challenge because they require intricate blood vessel networks (vascularisation) and multiple cell types working in precise coordination. Mini-organs called organoids — small three-dimensional models of organs grown from stem cells — are already being used for drug testing and studying diseases like cancer.
Explore stem cells, cell biology, and all KS3 science with Professor Darwin, your Socratic AI tutor — visit aitutors.me.